Sulfoxide-containing Polymers Conjugated Prodrug Micelles with Enhanced Anticancer Activity and Reduced Intestinal Toxicity.
Yechun Wang,Jiafeng Wang,Junjun Li,Yongli Mu,Jiajia Ying,Zimeng Liu,Mengjie Wu,Yu Geng,Xuefei Zhou,Tianhua Zhou,Youqing Shen,Leimin Sun,Xiangrui Liu,Quan Zhou
DOI: https://doi.org/10.1016/j.jconrel.2024.05.050
IF: 11.467
2024-01-01
Journal of Controlled Release
Abstract:Poly(ethylene glycol) (PEG) is widely utilized as a hydrophilic coating to extend the circulation time and improve the tumor accumulation of polymeric micelles. Nonetheless, PEGylated micelles often activate complement proteins, leading to accelerated blood clearance and negatively impacting drug efficacy and safety. Here, we have crafted amphiphilic block copolymers that merge hydrophilic sulfoxide-containing polymers (psulfoxides) with the hydrophobic drug 7-ethyl-10-hydroxylcamptothecin (SN38) into drug-conjugate micelles. Our findings show that the specific variant, PMSEA-PSN38 micelles, remarkably reduce protein fouling, prolong blood circulation, and improve intratumoral accumulation, culminating in significantly increased anti-cancer efficacy compared with PEG-PSN38 counterpart. Additionally, PMSEA-PSN38 micelles effectively inhibit complement activation, mitigate leukocyte uptake, and attenuate hyperactivation of inflammatory cells, diminishing their ability to stimulate tumor metastasis and cause inflammation. As a result, PMSEA-PSN38 micelles show exceptional promise in the realm of anti-metastasis and significantly abate SN38-induced intestinal toxicity. This study underscores the promising role of psulfoxides as viable PEG substitutes in the design of polymeric micelles for efficacious anti-cancer drug delivery.